Description

Quetiapine Fumarate Tablets IP 25 Mg – QETRONIX 25 Tablets
Composition  – Quetiapine Fumarate 25 mg

Description
Quetiapine Fumarate Tablets IP 25 mg contains Quetiapine, an atypical antipsychotic belonging to the dibenzothiazepine class, indicated for the management of schizophrenia, bipolar disorder, and as adjunctive therapy in major depressive disorder. It works by blocking dopamine D2 and serotonin 5-HT2A receptors in the brain, which helps to restore the balance of neurotransmitters and reduce psychotic symptoms. The 25 mg strength serves as a standard initiation dose, allowing gradual titration for better tolerability and patient compliance. It is widely used in both acute and maintenance treatment of psychiatric conditions under specialist supervision.

Key Points
Atypical Antipsychotic — Dual dopamine and serotonin receptor antagonist
Low Initiation Dose — 25 mg strength ideal for starting therapy and dose titration
Broad Psychiatric Indications — Effective in schizophrenia, bipolar mania, bipolar depression, and adjunctive MDD
Improved Tolerability — Lower risk of extrapyramidal side effects compared to typical antipsychotics
Sedative Properties — Beneficial in managing agitation, anxiety, and sleep disturbances associated with psychiatric disorders

Targeted Specialties
Psychiatry
Neurology
General Physician & Internal Medicine

Disclaimer: To be used under medical supervision only. Not intended for general public promotion. This content is meant for registered healthcare professionals only.